PTAB Litigation Blog
  • Home
  • Cookie Policy
  • About
  • Advanced Topics
  • Contributors
  • Contacts
  • Design Patents
  • Discovery
  • Joinder
Select Page
Typical Supplier/Co-Defendant Is Not An RPI Or Privy

Typical Supplier/Co-Defendant Is Not An RPI Or Privy

by Kenneth Luchesi | Dec 14, 2018 | Real Party in Interest

By Kenny Luchesi –  In a recently published decision, the PTAB held that Samsung’s petition for inter partes review of a patent owned by The SEVEN Networks LLC was not time-barred under § 315(b).  Samsung filed its petition less than one year after being...
Board Grants Discovery Regarding RPI Issues

Board Grants Discovery Regarding RPI Issues

by Albert Liou | Dec 11, 2018 | Discovery, Real Party in Interest

By Albert Liou –  In Cavium, LLC v. Alacritech, Inc., Case IPR2018-00401 (PTAB Nov. 20, 2018) (Paper 24), the PTAB granted a Patent Owner’s motion for additional discovery relating to real party-in-interest. The split-panel decision is interesting...
Challenges to Real Parties-in-Interest Continue to Terminate IPR Proceedings

Challenges to Real Parties-in-Interest Continue to Terminate IPR Proceedings

by S. Christian Platt | Mar 5, 2018 | Real Party in Interest

By: Jasper L. Tran and S. Christian Platt In prior blog posts, we have commented on PTAB decisions terminating IPR proceedings due to the Petitioner’s failure to identify all real parties-in-interest. See blog posts on Sanction For Failing to Update Real Party In...
PTAB Institutes Separate IPR Proceedings Filed by Codefendants, Finding that the Later IPR Proceeding Was Not Barred by 35 U.S.C. § 325(d)

PTAB Institutes Separate IPR Proceedings Filed by Codefendants, Finding that the Later IPR Proceeding Was Not Barred by 35 U.S.C. § 325(d)

by Cary Miller | Jan 30, 2017 | 325(d) issues, Pharmaceutical, Real Party in Interest

By Kunyong Yang and Cary Miller, Ph.D. On January 19, 2017, the PTAB instituted inter partes review of U.S. Patent No. 8,822,438 (“the ’438 patent”) filed by Wockhardt Bio AG (“Wockhardt”) (IPR2016-01582).  The ’438 patent is owned by Janssen Oncology, Inc....
Federal Circuit Agrees to En Banc Rehearing on Whether PTAB’s 1-Year-Bar Decisions Are Reviewable

Federal Circuit Agrees to En Banc Rehearing on Whether PTAB’s 1-Year-Bar Decisions Are Reviewable

by Matthew Johnson | Jan 4, 2017 | Federal Circuit Appeal, Real Party in Interest, Time Limits, Trial Institution

By Matt Johnson Today the Federal Circuit agreed to rehear en banc the panel decision in Wi-Fi One v. Broadcom Corp. on the issue of whether the PTAB’s findings regarding 35 U.S.C. § 315(b)’s one year bar can be reviewed on appeal.  This question tests the...
Continuously Keeping Your IPR Ducks in a Row: Sanctions for Failing to Update the PTAB on Changes in Real Parties of Interest

Continuously Keeping Your IPR Ducks in a Row: Sanctions for Failing to Update the PTAB on Changes in Real Parties of Interest

by Jones Day's PTAB Team | Dec 17, 2016 | Real Party in Interest

By Jaime D. Choi Ph.D. IPR petitions are required to identify “all real parties in interest,” among other things because the final written decision of the PTAB prevents the petitioner, the real party in interest, or privy of the petitioner to “request or maintain a...
« Older Entries
Next Entries »

About this blog

Follow us on Twitter

Categories

  • 325(d) issues
  • Amendment Practice
  • CBMs
  • Claim Construction
  • Design Patents
  • Discovery
  • Estoppel
  • Evidentiary Issues
  • Expert Witnesses
  • Federal Circuit
  • Federal Circuit Appeal
  • Final Written Decisions
  • Joinder
  • Motions Practice
  • Other News
  • Patent Eligible Subject Matter
  • Petitions
  • PGR
  • Pharmaceutical
  • Preliminary Responses
  • Prior Art Issues
  • PTAB News
  • PTAB Trial Basics
  • Real Party in Interest
  • Request for Reconsideration
  • Standing
  • Stay
  • Time Limits
  • Trial Institution
  • Uncategorized

Archives

Links

www.jonesday.com

About Jones Day's Intellectual Property Practice

Subscribe to Jones Day publications

  • Privacy
  • Facebook
  • Twitter
  • Google
  • RSS

The opinions expressed are those of the authors and do not necessarily reflect the views of Jones Day or its clients. The posts and information provided are for general information purposes and are not intended to be and should not be taken as legal advice.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies. Cookie Policy